Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis

• Main Authors: Xiaojian Qin, PhD (Author), Dingwei Ye, PhD (Author), Chengyuan Gu, PhD (Author), Yongqiang Huang, PhD (Author), Weijie Gu, PhD (Author), Bo Dai, PhD (Author), Hailiang Zhang, PhD (Author), Yao Zhu, PhD (Author), Han Yang, MS (Author), Shuli Qu, MPH (Author)
• Format: Book
• Published: Elsevier, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACT: Background: Both National Comprehensive Cancer Network and Chinese guidelines recommend beginning prostate-specific antigen (PSA) screening for men aged 50 years or 45 years with a family history because they were at a higher risk of developing prostate cancer. Several model-based economic...